Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Pieter H. Bos"'
Autor:
Pieter H. Bos, Evelyne M. Houang, Fabio Ranalli, Abba E. Leffler, Nicholas A. Boyles, Volker A. Eyrich, Yuval Luria, Dana Katz, Haifeng Tang, Robert Abel, Sathesh Bhat
Publikováno v:
Journal of Chemical Information and Modeling. 62:1905-1915
Autor:
Pieter H, Bos, Evelyne M, Houang, Fabio, Ranalli, Abba E, Leffler, Nicholas A, Boyles, Volker A, Eyrich, Yuval, Luria, Dana, Katz, Haifeng, Tang, Robert, Abel, Sathesh, Bhat
Publikováno v:
Journal of chemical information and modeling. 62(8)
The lead optimization stage of a drug discovery program generally involves the design, synthesis, and assaying of hundreds to thousands of compounds. The design phase is usually carried out via traditional medicinal chemistry approaches and/or struct
Autor:
Karl Leswing, Joshua Staker, Pieter H. Bos, Kyle Marshall, Sathesh Bhat, Phani Ghanakota, Kyle D. Konze, Gabriel Marques, Robert Abel
Publikováno v:
Journal of Chemical Information and Modeling. 60:4311-4325
The hit identification process usually involves the profiling of millions to more recently billions of compounds either via traditional experimental high-throughput screens (HTS) or computational virtual high-throughput screens (vHTS). We have previo
Autor:
Pieter H Bos, Evelyne M. Houang, Fabio Ranalli, Abba E. Leffler, Nicholas A. Boyles, Volker A. Eyrich, Yuval Luria, Dana Katz, Haifeng Tang, Robert Abel, Sathesh Bhat
The lead optimization stage of a drug discovery program generally involves the design, synthesis and assaying of hundreds to thousands of compounds. The design phase is usually carried out via traditional medicinal chemistry approaches and/or structu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88c2ba821dcd166570c44c7439ae5d47
https://doi.org/10.26434/chemrxiv-2021-m6k5f
https://doi.org/10.26434/chemrxiv-2021-m6k5f
Publikováno v:
Free Energy Methods in Drug Discovery: Current State and Future Directions ISBN: 9780841298064
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdef03a35a5faf6129752f02d2f99e3a
https://doi.org/10.1021/bk-2021-1397.ch008
https://doi.org/10.1021/bk-2021-1397.ch008
Autor:
Markus K. Dahlgren, Robert Abel, Bortolato Andrea, Pieter H. Bos, Karl Leswing, Kyle D. Konze, Ivan Tubert-Brohman, Sathesh Bhat, Braxton Robbason
Publikováno v:
Journal of Chemical Information and Modeling. 59:3782-3793
The hit-to-lead and lead optimization processes usually involve the design, synthesis, and profiling of thousands of analogs prior to clinical candidate nomination. A hit finding campaign may begin with a virtual screen that explores millions of comp
Autor:
Marcel M. Dupont, Yan Zhang, Pieter H. Bos, Huizhong Feng, Jennifer M. Chambers, Brent R. Stockwell
Publikováno v:
Biochemistry. 58:2542-2554
KRAS is the most commonly mutated oncogene in human cancer, with particularly high mutation frequencies in pancreatic cancers, colorectal cancers, and lung cancers [Ostrem, J. M., and Shokat, K. M. (2016) Nat. Rev. Drug Discovery 15, 771–785]. The
Autor:
Sathesh Bhat, Kyle D. Konze, Phani Ghanakota, Pieter H. Bos, Gabriel Marques, Karl Leswing, Kyle Marshall, Robert Abel, Joshua Staker
The hit identification process usually involves the profiling of millions to more recently billions of compounds either via traditional experimental high throughput screens (HTS) or computational virtual high throughput screens (vHTS). We have previo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a295f99efe3522f4a557fedd89728ac8
https://doi.org/10.26434/chemrxiv.11825679
https://doi.org/10.26434/chemrxiv.11825679
Autor:
Amy Y. Chan, Daniel W. Heindel, Christopher A. Vaiana, Jacob D. Daniels, Michael M. Gaschler, Yulia Y. Tyurina, Andrei V. Bekish, Pieter H. Bos, Lingplak Ye, Vadim V. Shmanai, Brent R. Stockwell, Lara K. Mahal, Eveliz Peguero-Pereira, Mikhail S. Shchepinov, Joleen M. Csuka, Eduard Reznik, Alexander A. Andia, Hengrui Liu, K. A. Woerpel, Valerian E. Kagan, Maksim A. Fomich, Annie J. Lin, Brisa Hurlocker, Dylan S. Zuckerman
Publikováno v:
Nature Chemical Biology. 14:507-515
Ferroptosis is a non-apoptotic form of regulated cell death caused by the failure of the glutathione-dependent lipid-peroxide-scavenging network. FINO2 is an endoperoxide-containing 1,2-dioxolane that can initiate ferroptosis selectively in engineere
Autor:
Kira A. Armacost, David C. Thompson, Zoe Cournia, Christophe Chipot, Benoît Roux, Darrin M. York, Woody Sherman, Katharina Meier, Joseph P. Bluck, Clara D. Christ, Nicolas Tielker, Lukas Eberlein, Oliver Beckstein, Stefan Güssregen, Bogdan I. Iorga, Stefan M. Kast, Shuai Liu, Miroslav Suruzhon, Marley L. Samways, Jonathan W. Essex, Ayşegül Özen, Emanuele Perola, Natasja Brooijmans, Joseph Kim, Dilek Coskun, Tai-Sung Lee, Hsu-Chun Tsai, Abir Ganguly, Timothy J. Giese, Jennifer L. Knight, Karl Leswing, Pieter H. Bos, Lingle Wang, Paul Labute, Maximilian Ebert, Lance M. Westerhoff, Zheng Zheng, Eric C. Gladstone
'This book is about Free Energy Methods in Drug Discovery: Current State and Future Directions'--